Interestingly, one of the patients used in the RNA-Seq experiments was classified as HER2− based on the pathological report; however, the expression of HER2 mRNA transcript was elevated based on the RNA-Seq data, suggesting possible differences in the pathological and molecular assessment of HER2 expression in breast cancer. The gene discussed is ERBB2; the disease is breast cancer.